Campbell Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-388
Closed -$20K 82
2020
Q2
$20K Buy
+388
New +$16.6K ﹤0.01% 209

Other funds holding ARKG

Campbell Wealth Management's ARKG Position: Q3 2020 in Review

Campbell Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2020, closing a stake of 388 shares — an estimated $20K sold.

Campbell Wealth Management first reported a position in ARKG in Q2 2020 and held it in 1 quarter. The position peaked at $20K in Q2 2020. 243 funds tracked by Wall St. Rank hold ARKG as of Q3 2020.

  • Campbell Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q3 2020 after selling out during the quarter.
  • Campbell Wealth Management sold 388 ARK Genomic Revolution ETF shares in Q3 2020, an estimated $20K.
  • Campbell Wealth Management first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 1 quarter.
  • Campbell Wealth Management's ARK Genomic Revolution ETF position peaked at $20K in Q2 2020.
  • 243 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2020.

Based on Campbell Wealth Management's 13F filing for Q3 2020, filed 2 Nov 2020.